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Evaluation of a Collagen Membrane
With and Without Bone Grafts in
Treating Periodontal Intrabony Defects
Chuan-Chuan Chen* Horn-Lay Wang^ Frederic Smithy Gerald N. Glickman* Yu
Shyr* and Robert B. O'Neal*
The aim of this study was to compare the clinical regenerative capacity of collagen
membrane with and without demineralized freeze-dried bone allografts (DFDBA) in
treating periodontal intrabony defects. Ten systemically healthy patients with similar
bilateral periodontal defects were scheduled for surgery. Each patient had at least >
6 mm clinical probing depth and loss of attachment at selected sites. Baseline mea-
surements included gingival index (GI), plaque index (PI), gingival recession (GR),
clinical attachment level (CAL), probing depth (PD), and mobility. At the time of
surgery, the defects were randomly assigned to either test (collagen membrane plus
DFDBA) or control group (collagen membrane only). Stent to base of the defects,
stent to crest bone, crest of bone to base of the defect, and width of the defects were
recorded at the time of surgery and reentry. Eight patients returned after 6 months for
reentry surgery. Statistical analysis with a paired t test was used to evaluate the treat-
ment effect and comparison between test and control groups. In addition, a McNemar
test was used to analyze the significance of GI, PI, and mobility at different times.
The result of this study indicated that both the collagen plus DFDBA and the collagen
alone treatment groups had a significant decrease of PD (3.4±0.4 and 3.2±0.4 mm),
gain of CAL (2.3±0.5 and 2.0±0.4 mm), and defect fill (1.7±0.3 and 1.9±0.9 mm)
(P < 0.05) when compared to the presurgery status. However, there was no significant
difference in PD, AL, GR, defect fill, crestal bone résorption, Gl, PI, or mobility
between the test group and control group. No adverse tissue reaction, infection, or
delayed wound healing was noted throughout the treatment in either group. This study
suggests that the collagen membrane is well tolerated by the human tissues. Both
treatments, either collagen membrane plus DFDBA or collagen membrane alone, pro-
moted significant resolution of periodontal intrabony defects. The addition of a bone
graft (DFDBA) with a collagen membrane appears to add no extra benefit to the
collagen membrane treatment. J Periodontol 1995;66:838-847.
Key Words: Collagen/therapeutic use; guided tissue regeneration; bone, grafts; bone,
freeze-dried; periodontal diseases/therapy; membranes, barrier; membranes, artificial.
Connective tissue cells in gingival corium, periodontal
ligament, cementum, and bone represent different phe-
notypes and it is the phenotype of the cells repopulating
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an area after wounding that determined the character of
the regenerative response.1 Studies in animals and hu-
mans, using either expanded polytetrafluoroethylene
(ePFTE)1 membranes or Millipore* filters, resulted in the
formation of more new attachment when compared to
controls both clinically and histologically.2^1 However, a
second surgical procedure to remove the membrane is an
additional burden to both clinician and patient. Efforts are
being directed to developing a barrier membrane which
'W.L. Gore and Associates, Flagstaff, AZ.
•Millipore SA, Molsheim, France.
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is fully absorbable, such as a processed bovine collagen
membrane. The absorbable collagen membrane can act as
a barrier analogous to a nonabsorbable membrane and it
is either incorporated into the healing connective tissues
or is degraded by macrophages in 6 to 8 weeks. Exoge-
nous collagen is chemotactic for periodontal ligament fi-
broblasts and also improves fibroblast migration and at-
tachment through its scaffold-like fibrillar structure.5 It
also creates a thrombogenic surface that stimulates plate-
let attachment which may accelerate fibrin and clot at-
tachment.6 These biological properties of collagen may
aid in periodontal reconstructive procedures. Numerous
studies have proven the effectiveness of using collagen
membranes in guided tissue regeneration (GTR) ther-
apy.7-13 A previous study has demonstrated that sites treat-
ed with a collagen barrier exhibited a statistically signif-
icant higher bone fill and improvement of furcation hor-
izontal bone repair and defect improvement than the sites
treated without a collagen barrier.14
The effect of combining a bone graft with GTR ma-
terial has been evaluated.15"17 Anderegg et al.15 used
freeze-dried bone allograft in promoting regeneration of
Class II furcation involvements. In sites treated with bone
grafts, formation of new cementum and connective tissue
attachment was observed. However, no evidence of new
bone formation was reported in the group without using
bone grafts. When porous hydroxyapatite was used in
conjunction with an ePTFE membrane, less gingival re-
cession and more defect fill were obtained.16 Apposition
of alveolar bone was noted in dehiscence and horizontal
defects when osseous composite grafting, root condition-
ing with citric acid, and membrane were used together as
compared to the membrane only treated sites.17 When col-
lagen gel was combined with bony grafts in a 1:1 ratio
by volume in treating periodontal intrabony defects in
dogs, Blumenthal and coworkers noticed that it offered
advantages over the bone graft alone.18 Nery and col-
leagues found the use of combined biphasic calcium
phosphate ceramic and fibrillar collagen to be beneficial
in promoting new attachment of periodontal tissues to the
tooth root surfaces in dogs.19 In addition, a positive result
was reported in the sites treated with supracrestal trical-
cium phosphate ceramic and collagen grafts when com-
pared to the collagen grafts control sites in a human
study.20 Other studies have also shown that collagen mem-
branes combined with bone grafts are effective in treating
intrabony defects.21-22 On the contrary, Caffesse et al.
found that GTR procedures resulted in an increase in con-
nective tissue and alveolar bone regeneration, but adjunc-
tive bone grafting did not appear to enhance regenera-
tion.23 In promoting bone formation around immediate
dental implants, the addition of DFDBA to ePTFE mem-
brane was questioned as a method to regenerate bone.24
Due to these conflicting reports in the literature, it is the
aim of this study to compare the clinical regenerative abil-
ity of intrabony defects treated with collagen membranes
either with or without bone grafts.
MATERIAL AND METHODS
Patient Selection
This research is an expansion of an ongoing absorbable
collagen membrane clinical trial in the Department of
Graduate Periodontics at The University of Michigan,
School of Dentistry. The protocol was approved by the
Human Subject Review Committee at The University of
Michigan for clinical use. Ten systemically healthy pa-
tients, 6 males and 4 female, aged from 26 to 62, were
included in this study. Patients entered the study either
directly after a standard preparation stage (i.e., oral hy-
giene instruction, scaling and root planing, and other ini-
tial disease control procedures) or upon the decision that
surgical intervention was needed during maintenance
therapy. The following criteria were used to select the
subjects for this clinical study: 1) evidence of moderate
or advanced Periodontitis; 2) similar intraosseous defects
exhibiting attachment loss & 6 mm and probing depths
a 6 mm; 3) radiographie evidence of intrabony vertical
defect; 4) no antibiotic therapy in the past 6 months; and
5) no periodontal surgery within the last 12 months. In-
formed consents from all patients who met the criteria
and agreed to participate in the study were obtained.
Measurements
Clinical data included probing depths (PD) of the peri-
odontal defects; clinical attachment levels (CAL); gingi-
val recession (GR); mobility; and plaque (PI) and gingival
(Gl) indices were collected at baseline (at the time of the
surgery) and at 1, 2, 3, and 4 weeks and 6 months after
surgery. An acrylic resin surgical Stent was made for each
patient. Measurements were taken from this surgical stent
with a ledge and vertical grooves (Fig. 1) pre- and post-
surgically. PD were obtained using a North Carolina 15
mm probe: the deepest point at defect site from the stent
vertical groove of selected tooth was recorded. CAL was
obtained from reference points (surgical stent) to the base
of the periodontal defect by using an automated probe**
to reduce any measuring errors. GR was measured from
the stent to the free gingival margin on the defect site.
Tooth mobility was detected utilizing Miller's classifica-
tion (0 = no mobility; 1 = the first distinguishable sign
of movement greater than normal; 2 = movement of 1
mm from normal position in any direction; and 3 = move-
ment of more than 1 mm in any direction).25 PI was re-
corded according to Silness and Löe.26 Gl was measured
using the criteria described by Löe and Silness.27 The fol-
lowing measurements were taken: stent to the base of de-
fect (SB), crest of bone to base of defect (CB), and bucco-
**Florida Probe Co., Gainesville, FL.
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Figure 1. Demonstrates how the clinical measurements were taken from
the surgical Stent ledge and grooves.
lingual/mesio-distal morphology of the intrabony defects,
at the time of surgery, and at 6 months re-entry surgery.
Surgical Protocol
All surgical procedures were carried out from February
1993 to July 1994 in the surgery clinic of Graduate Per-
iodontics at The University of Michigan, School of Den-
tistry. Defects were randomly assigned (by flipping a
coin) to treatment of using collagen membranes either
with or without demineralized freeze-dried bone allografts
(DFDBA).** Following adequate local anesthesia, internal
beveled incisions were made buccally and lingually in the
test and control sites with the intention to preserve the
interdental papilla. The defects were debrided and all root
surfaces were completely scaled and root planed by ul-
trasonic, hand instrumentation, and rotary burs to a
smooth and hard consistency. Minor osteoplasty without
removal of any supporting bone was performed to facil-
itate proper flap adaptation. Absorbable collagen mem-
branes** (prepared from purified bovine Achilles tendon
in a chemically cross-linked form and supplied in indi-
vidual 18 mm X 38 mm X 0.15 to 0.22 mm sterile pieces)
were cut, fitted, and placed over the defects on both test
and control sides. The membrane was sutured with 5-0
chromic gut sutures if it did not sit uniformly over the
osseous defect, otherwise no suture was used. In the test
group, a DFDBA bone graft implant material was pre-
pared in a sterile dappen dish to a paste-like consistency
and was implanted into the intrabony defects with inten-
tion of slightly overfilling. The flap was subsequently su-
tured into its original position with 4-0 black silk sutures.
On the control side, all surgical procedures were identical
except that no bone graft was placed. The surgical pro-
cedure of placing collagen membrane is shown in Figure
2. Patients then received routine written and oral post-
operative instructions. All the patients were prescribed
with doxycycline 100 mg/day for 2 weeks and were also
instructed to rinse with 0.12% Chlorhexidine gluconate for
a period of 4 weeks. The 4-0 silk sutures were removed
one week after the surgery. Patients returned weekly for
4 weeks for observation of any adverse tissue reactions.
Patients were then seen at 2, 4, and 6 months postsurgery
for tissue evaluation, plaque debridement, and oral hy-
giene review.
Six Months Re-Entry Surgery
At the end of 6 months, the patients were scheduled for
re-entry surgery. Clinical measurements (Gl, PI, PD,
CAL, Stent to the free gingival margin, and mobility) of
the involved tooth were recorded prior to the surgery.
Surgical re-entry consisted of sulcular incisions to pre-
serve attached gingiva and interdental papillae. Full-
thickness mucoperiosteal flaps were designed to expose
the previously treated defect areas for clinical photo-
graphs and measurements as previously described. Flaps
were then replaced and sutured. Patients were seen at 1
week postsurgery for suture removal, and then placed on
a closely supervised 3-month schedule for supportive
periodontal treatment.
Statistical Analysis
The data were organized and presented as means ± stan-
dard error and analyzed using the SAS system.85 The
McNemar test and the paired t test were utilized to de-
termine the significance of changes over time and clinical
parameters with respect to treatment modality. Signifi-
cance was reported at the 95% confidence level (a =
0.05). Under a = 0.05 statistical power set at 0.80, eight
patients are needed to show a statistically significant dif-
ference between treatments with a change in CAL of 1
mm and a standard deviation set at 0.5. However, if the
standard deviation is set at 0.8, then the number should
be increased to 14 to indicate the difference.
RESULTS
Ten patients, 4 females and 6 males with an age range of
26 to 62 (mean age, 38.2) years old, participated in this
study. Of the 20 teeth selected, one site did not qualify
for the research at the time of surgery. Therefore 10 teeth
were treated with flap surgery followed by a combination
of DFDBA and collagen membrane, whereas the remain-
ing 9 teeth were treated with the same flap surgery but
without bone grafts (collagen membrane only). Patients
were seen at baseline, 1, 2, 3, 4, 8, and 12 weeks and re-
entry surgery was performed from 6 to 12 months after
"LifeNet, Virginia Beach, VA.
«BioMed, Calcitele, Inc., Carlsbad, CA. 'SAS Institute, 6.04 SAS, Cary, NC.
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Figure 2. Surgical procedures for Patient 1. All photographs represent
a mirror image. 2A. Presurgery status.
2B. Sulcular incision made in order to preserve all the interdental pa-
pillae.
2C. Defects dehrided and measurements made from the Stent.
surgery. Two patients did not return for re-entry surgery:
one moved away and the other refused to have re-entry
surgery. Hence only 8 patients had re-entry surgery (2 at
6 months; 5 at 7 months; and 1 at 12 months). Clinical
and radiographie comparisons, both presurgically and
postsurgically, are shown in Figures 2 and 3. Patient de-
mographic information is shown in Table 1.
2D. Membrane was placed over the defect without suturing.
2E. Flap positioned coronally and primary coverage achieved over the
membrane.
2F. Re-entry surgery showing the new bone formation with probe in
place.
During the course of this study, no adverse tissue re-
action, infections, or delayed healing were reported. As
demonstrated in Table 2, there were no significant
changes in GI, PI, and mobility in either test or control
sites between baseline; 1, 2, and 4 weeks; and upon re-
entry surgery.
J Periodontol
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Figure 3. Patient 5 Collagen + DFDBA (#28) and collagen only treated
sites (#27). All photographs represent a mirror image. 3A. Initial defects.
3C. Presurgical periapical radiograph.
3B. Re-entry surgery showing the newly formed bone and dense tissues.
Table 3 represents the baseline and 6-month re-entry
measurements, whereas Table 4 compares the difference
between the treatment groups. No difference was noted
on all soft tissue measurements (PD, CAL, and GR) at
baseline and 6-month re-entry between collagen +
3D. Postsurgical periapical radiograph (arrows indicate the radio-
graphic base of the defect).
DFDBA and collagen membrane treated sites. The mean
PD improvement for the collagen + DFDBA treated de-
fects was 3.4 mm as compared to 3.2 mm for the controls.
When the 6-month re-entry values were compared to the
baseline measurements, both treatment modalities showed
significant reduction of PD from baseline. Collagen +
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Table 3. Clinical Measurements for Collagen + DFDBA and Col-
lagen (control) Groups at Baseline and Re-entry (n = 7 in collagen
+ DFDBA group;  = 8 in collagen group)
Collagen + DFDBA Collagen
Measurements Baseline Re-entry Baseline Re-entry
Soft tissue




Stent to base of defect 12.5





7.4 ± 0.4 4.2 ± 0.4
11.1 ±0.5 9.1 ±0.8
3.7 ±0.4 4.7 ±0.4 4.1 ± 0.5 5.4 ± 0.5
: 0.6 10.8 ± 0.8
: 0.4 8.4 ± 0.5
13.2 ± 0.7 11.3 :
8.4 ± 0.5 8.9 :
1.0
1.0
DFDBA and collagen membrane treated sites showed a
statistically significant gain of CAL (2.3 mm and 2.0 mm,
respectively) when compared to the presurgery status.
Paired t test indicated that the gain of CAL was not sig-
nificantly different between two groups, but the test group
had a slight tendency to gain more CAL than the control
group. No difference was noted between test and control
sites with regards to GR, either pre- or postsurgically.
Hard tissue measurements including SB, CB, and width
of the defects, both bucco-lingual and mesio-distal, were
recorded during the surgery. The differences of SB be-
tween baseline and re-entry represent the amount of ver-
tical bone defect fill. The collagen + DFDBA and col-
lagen barrier treated sites showed significant improve-
ments in defect fill (P < 0.01) as compared to the pre-
surgery status. However, no statistically significant
difference was noted between the two groups (1.7 ± 0.3
mm vs. 1.9 ± 0.9 mm). Table 5 indicates that 3 out of 7
sites treated with collagen + DFDBA had more than 50%
of defect fill as compared to 5 out of 8 sites in membrane
treated control group. No difference was found in CB
between test and control sites at 6 months re-entry.
The eresiai bone résorption was obtained from the dif-
ference of stent to crest of bone between baseline and 6
months. The amount of crestal bone résorption was sim-
ilar in both collagen + DFDBA and collagen membrane
treated sites (0.7 mm vs. 0.5 mm); there was no statisti-
cally significant difference between the two groups. When
considering the bucco-lingual width measurements, both
treated groups showed an improvement (1.8 mm for the
collagen group and 1.4 mm for the collagen + DFDBA)
when compared to the baseline; however, no statistically
Table 4. Clinical Changes at 6-Month Re-entry (n = 7 in collagen












3.4 ± 0.4* 3.2 ± 0.4*
2.3 ± 0.5* 2.0 ± 0.4*












 Statistically significant difference from the baseline.
No statistically significant differences were found between the two treat-
ment groups.
Table 5. Percentage of Defect Fill after 6 Months (n = 7 in collagen
+ DFDBA group and  = 8 in collagen group)
Group None 0-25% 25-50% >50%
Collagen + DFDBA
Collagen
significant difference was noted between the two groups.
A statistically significant reduction of mesio-distal width
was noted in the collagen treated groups but not in the
collagen + DFDBA treated groups. No difference was
found between the two groups at baseline and re-entry.
DISCUSSION
Guided tissue regeneration (i.e., epithelial exclusion and
selective repopulation of the root surface by multipoten-
Table 2. Comparison of Clinical Parameters Between Collagen + DFDBA and Collagen (control)
(mean ± standard error) at Different Time Periods (n = 8)
Parameters Group Baseline 1 Week 2 Weeks 4 Weeks 6 Months
Gingival index Collagen + DFDBA 0.4 ± 0.2 0.7 ± 0.2 0.7 ± 0.3
Collagen 0.6 ± 0.4 0.8 ± 0.2 0.8 ± 0.2
Plaque index Collagen + DFDBA 0.3 ± 0.2 0.3 ± 0.2 0.3 ± 0.2
Collagen 0.3 ± 0.2 0.3 ± 0.2 0.1 ± 0.1
0.6 ± 0.2 0.4 ± 0.2
0.5 ± 0.2 0.4 ± 0.2
0.0 ± 0.0 0.4 ± 0.1
0.1 ±0.1 0.1 ±0.1
Nò statistically significant difference.
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tial cells) utilizing non-absorbable occlusive membranes
(such as an ePTFE membrane) has become an accepted
mode of therapy in periodontics.28,29 However, several
drawbacks have been documented including the need for
a second surgical procedure to retrieve the membrane
which may disrupt healing and could create further bone
and attachment loss. Clinical trials using absorbable col-
lagen membranes have shown them also to be effective
in treating periodontal defects.8,914 Collagen membranes
have been used because collagen is the most abundant
protein in the body and the main constituent of periodon-
tal connective tissue. In addition, the collagen membrane
has the following properties: it is a weak immunogen,30
it provides a scaffold for PDL cell migration,31 it is che-
motactic for fibroblasts5 and it can be easily manipulated
and adapted. These properties make it attractive for use
in GTR procedures.
Results from this study reported no adverse tissue re-
action, infections, or delayed healing. It was initially be-
lieved that an inflammatory reaction might occur follow-
ing the implantation of the collagen material due to its
non-human origin. However, the GI and PI were low at
both test and control sites at all time periods during the
experiment. This is in agreement with Blumenthal8 and
previous findings.14 These findings imply that the collagen
membrane is a biocompatible and safe material for use in
humans. Furthermore, Quteish et al., using light and elec-
tron microscopy to test the biocompatibility, résorption,
and penetration characteristics of human collagen graft
material, concluded that the inflammatory reaction occur-
ring after the implantation of collagen is slight and will
eventually resolve,31 as observed in this study.
Opinions on the effectiveness of DFDBA during GTR
are varied.23,32 DFDBA has been used during GTR pro-
cedures because it is thought to be a space filler and to
enhance periodontal tissue regeneration by its osteoin-
ductive properties.32 McClain and Schallhorn have dem-
onstrated that the long-term success of GTR is signifi-
cantly enhanced by the addition of root conditioning and
grafting procedures.33 Anderegg et al. also reported that
the addition of bone grafts during the GTR procedure
resulted in significantly more PD reduction than the mem-
brane only group.15 On the other hand, some groups feel
that bone grafts during GTR may block cell migration
and inhibit the regenerative potential.23 These results in-
dicated that both treatments (collagen membrane with or
without bone grafts) had significant effects on soft tissue
measurements by reducing PD and gaining in CAL. How-
ever, there was no statistically significant gain in PD re-
duction or gain in CAL by adding bone grafts to collagen
GTR procedures. Blumenthal and Steinberg used a com-
bined graft of autolysed antigen-extracted allogenic bone
and microfibrillar collagen with an absorbable collagen
membrane in treating human intrabony defects.21 They
found PD reduction similar to that observed in the present
study. Variations in results between studies can be ex-
plained by many factors such as differences in the mea-
suring techniques (stent vs. no stent, manual probe vs.
automated probe), the nature and extent of the defects,
and patient oral hygiene and compliance. Further studies
are needed to clarify the true benefit of using DFDBA
during GTR.
The amount of gingival recession found in the present
study averaged 1.0 and 1.3 mm in both groups. This result
is in agreement with most other GTR studies.14,21,34,35 Blu-
menthal and Steinberg reported a 0.96 mm of GR in col-
lagen membrane treated sites and 0.91 mm in the com-
bination therapy sites.21 Guillemin et al. demonstrated 0.9
mm of GR in sites treated with a bone graft combined
with a collagen membrane.34 Furcation defects treated
with ePTFE membrane alone had 1.3 mm of GR was
reported by Becker;35 this amount of gingival recession is
similar to that formed as a result of conventional flap
surgery. In a previous study, the regenerative capacity of
collagen membranes was evaluated by comparing it to the
treatment effect of conventional flap surgery.14
Blumenthal has reported less GR at the sites treated
with supracrestal tricalcium phosphate ceramic and col-
lagen grafts than compared to the non-grafted sites.20 Le-
kovic et al. also showed that bone grafts reduced the in-
cidence of gingival recession during GTR procedures.16
These findings are further supported by Anderegg et al.15
Different osseous defects used and different methods cho-
sen to measure the GR may explain the variation in results
reported.
Hard tissue measurements were taken after the flap was
reflected and the defect was debrided completely. Some
tough fiber-like tissue was noticed inside several residual
defects at the 6-month re-entry surgery (Fig. 3). It was
firmer and denser than regular granulation tissue and was
difficult to remove and probe. The nature of this type of
tissue needs to be further investigated histologically. The
outcome of the present study demonstrated significant de-
fect fill in both the test and control groups (P < 0.01) as
compared to their presurgical status. However, no statis-
tically significant difference was noted between the two
groups (1.7 ± 0.3 mm vs. 1.9 ± 0.9 mm). The results of
the present study differ from other studies.15,36 Anderegg
et al.15 and Wallace et al.36 found more defect fill in the
combined ePTFE membrane and bone graft group than in
the membrane only group when treating furcation defects.
In addition, treatment of intraosseous defects by combin-
ing an ePTFE membrane and bone graft can produce
greater defect fill than with bone grafts alone (1.9 mm vs.
2.2 mm).32 By using a collagen membrane instead of an
ePTFE membrane to treat intraosseous defects, Blumen-
thal and Steinberg obtained greater defect fill in a com-
bination therapy group than in a membrane group (3.71
mm vs. 1.83 mm).21 When freeze-dried bone allografts
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were combined with polyglactin 910 membranes1111 to treat
periodontal defects, more bone formation occurred at the
grafted sites than at the sites treated without bone
grafts.37-38 These studies may agree with Urist et al.,31 who
reported that demineralized bone grafts greatly enhance
osteogenic potential by providing a source of bone mor-
phogenic protein which stimulates bone formation by os-
teoinduction. However, Caffesse et al. found that adjunc-
tive bone grafting (xenograft) did not appear to enhance
regeneration when using ePTFE in treating furcation de-
fects in dogs.23 Similar results have also been reported in
immediate implant placement; the addition of DFDBA
(xenograft) to ePTFE membrane did not add any addi-
tional benefit to the membrane.24 A recent study by Beck-
er et al. has also questioned the use of DFDBA as a bone
inductive graft material in extraction sockets in humans.39
These studies, including the present study, may indicate
that the quantity of .bone morphogenic protein in grafts
(either homograft or xenograft) is insufficient to influence
the clinical outcome, as reported by Rummelhart et al.40
The percentage of defect fill in the present study was
41% in the test group (collagen + DFDBA) and 38% in
the control group (collagen only). The result was a little
less than that found in the other regeneration studies.34-41-42
For example, the percentage of defect fill in intraosseous
defects in the Guillemin study was 58% in the control
group (DFDBA only) and 71% in the test group (ePTFE
+ DFDBA).34 This can be explained by the fact that
"open probing new attachment" was used to evaluate the
defect fill within furcation areas, a technique conducted
by most investigators.35 This method measures both soft
or hard tissues around the original defect after the flap is
reflected at reentry surgery. Therefore, when "open prob-
ing new attachment" is used in evaluating the defect fill,
the results should be better, since the measurement was
taken from the new soft tissue instead of from the hard
tissue. In contrast, this study measured only newly formed
hard tissue (i.e., defects were completely debrided before
the measurement was taken).
The crestal bone résorption was not significantly dif-
ferent between the test and control groups in this study.
The mean crestal bone résorption was greater in the pres-
ent study than other studies.15-2' It averaged 0.1 to 0.25
mm in those studies but was 0.5 to 0.7 mm in the present
study. Our data seem to be in agreement with the previous
study by Wood et al., who has reported a mean reduction
of alveolar crest height of 0.62 mm after elevation of a
full-thickness flap.43
The other two components of an intrabony defect are
bucco-lingual and mesio-distal. Unlike the vertical com-
ponent mentioned earlier, there was no significant defect
fill in these two dimensions except in one group. A sig-
nificant mesio-distal defect fill (0.8 ± 0.2 mm) was ob-
"Vicryl, Johnson & Johnson Consumer Products, Skillman, NJ.
served postsurgically in the control group (P < 0.01).
Very few studies use this parameter due to the difficulty
of obtaining proper measurements. A defect extending
from the interproximal area to the line angle makes defect
measurement complicated.
Previous GTR investigations have primarily concen-
trated on dehiscence and furcation lesions in animal stud-
ies and furcation lesions in human trials.3-35-44-45 Very few
studies have evaluated the treatment of intraosseous de-
fects with guided tissue regeneration, which account for
most of the periodontal defects. In fact, interproximal de-
fects offer different therapeutic challenges which are not
experienced with furcation defects.34 Firstly, the mor-
phology of an interproximal defect is difficult to access
before the surgery. Secondly, it is difficult to perform
adequate debridement because the width of the vertical
defect is often insufficient to allow entry of an instrument
to the base of the defect. Thirdly, proper placement of the
membrane over the interproximal defect and complete
coverage of the membrane with the flaps is technically
demanding.
Limitations of this study include small sample size,
short study period, and lack of a negative control. A lon-
ger follow-up period (more than 12 months) and a larger
sample size with an experimental design including flap
surgery alone (negative) control, bone graft only (positive
control), membrane only, and membrane combined with
bone graft groups could be beneficial. Due to the nature
of clinical trials and a number of other factors, these de-
sired conditions were not feasible. A real difference be-
tween treatment groups may have existed if the sample
size had been larger. Hence, further study with a larger
sample size is needed. An additional incremental study is
currently being conducted to answer some further ques-
tions.
From this limited study, the following conclusions can
be drawn: 1) In treating intrabony periodontal defects,
using either a collagen membrane or a collagen membrane
in combination with a bone graft, resulted in a significant
decrease of probing depth, gain of new attachment, and
defect fill. 2) The addition of a bone graft (DFDBA) to a
collagen membrane does not add additional benefit to the
collagen membrane alone treatment. 3) Collagen mem-
branes are well-tolerated by human tissues. 4) Further
studies are required to clarify the osteogenic potential of
DFDBA, especially when used in combination with bar-
rier membranes.
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